Cargando…

Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy

PURPOSE: To investigate the value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the differential diagnosis of lymphoma in patients with fever of unknown origin (FUO) accompanied by lymphadenopathy and to develop a simple scoring system to di...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia, Xu, Dong, Sun, Wen-Jin, Wang, Wen-Xia, Xie, Na-Na, Ruan, Qiu-Rong, Song, Jian-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374793/
https://www.ncbi.nlm.nih.gov/pubmed/36884116
http://dx.doi.org/10.1007/s00432-023-04665-7
_version_ 1785078854142918656
author Chen, Jia
Xu, Dong
Sun, Wen-Jin
Wang, Wen-Xia
Xie, Na-Na
Ruan, Qiu-Rong
Song, Jian-Xin
author_facet Chen, Jia
Xu, Dong
Sun, Wen-Jin
Wang, Wen-Xia
Xie, Na-Na
Ruan, Qiu-Rong
Song, Jian-Xin
author_sort Chen, Jia
collection PubMed
description PURPOSE: To investigate the value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the differential diagnosis of lymphoma in patients with fever of unknown origin (FUO) accompanied by lymphadenopathy and to develop a simple scoring system to distinguish lymphoma from other etiologies. METHODS: A prospective study was conducted on patients with classic FUO accompanied by lymphadenopathy. After standard diagnostic procedures, including PET/CT scan and lymph-node biopsy, 163 patients were enrolled and divided into lymphoma and benign groups according to the etiology. The diagnostic utility of PET/CT imaging was evaluated, and beneficial parameters that could improve diagnostic effectiveness were identified. RESULTS: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PET/CT in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy were 81.0, 47.6, 59.3, and 72.7%, respectively. The lymphoma prediction model combining high SUVmax of the “hottest” lesion, high SUVmax of the retroperitoneal lymph nodes, old age, low platelet count, and low ESR had an area under the curve of 0.93 (0.89–0.97), a sensitivity of 84.8%, a specificity of 92.9%, a PPV of 91.8%, and an NPV of 86.7%. There was a lower probability of lymphoma for patients with a score < 4 points. CONCLUSIONS: PET/CT scans show moderate sensitivity and low specificity in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy. The scoring system based on PET/CT and clinical parameters performs well in differentiating lymphoma and benign causes and can be used as a reliable noninvasive tool. REGISTRATION NUMBER: This study on FUO was registered on http://www.clinicaltrials.gov on January 14, 2014, with registration number NCT02035670. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04665-7.
format Online
Article
Text
id pubmed-10374793
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103747932023-07-29 Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy Chen, Jia Xu, Dong Sun, Wen-Jin Wang, Wen-Xia Xie, Na-Na Ruan, Qiu-Rong Song, Jian-Xin J Cancer Res Clin Oncol Research PURPOSE: To investigate the value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in the differential diagnosis of lymphoma in patients with fever of unknown origin (FUO) accompanied by lymphadenopathy and to develop a simple scoring system to distinguish lymphoma from other etiologies. METHODS: A prospective study was conducted on patients with classic FUO accompanied by lymphadenopathy. After standard diagnostic procedures, including PET/CT scan and lymph-node biopsy, 163 patients were enrolled and divided into lymphoma and benign groups according to the etiology. The diagnostic utility of PET/CT imaging was evaluated, and beneficial parameters that could improve diagnostic effectiveness were identified. RESULTS: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PET/CT in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy were 81.0, 47.6, 59.3, and 72.7%, respectively. The lymphoma prediction model combining high SUVmax of the “hottest” lesion, high SUVmax of the retroperitoneal lymph nodes, old age, low platelet count, and low ESR had an area under the curve of 0.93 (0.89–0.97), a sensitivity of 84.8%, a specificity of 92.9%, a PPV of 91.8%, and an NPV of 86.7%. There was a lower probability of lymphoma for patients with a score < 4 points. CONCLUSIONS: PET/CT scans show moderate sensitivity and low specificity in diagnosing lymphoma in patients with FUO accompanied by lymphadenopathy. The scoring system based on PET/CT and clinical parameters performs well in differentiating lymphoma and benign causes and can be used as a reliable noninvasive tool. REGISTRATION NUMBER: This study on FUO was registered on http://www.clinicaltrials.gov on January 14, 2014, with registration number NCT02035670. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04665-7. Springer Berlin Heidelberg 2023-03-08 2023 /pmc/articles/PMC10374793/ /pubmed/36884116 http://dx.doi.org/10.1007/s00432-023-04665-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Chen, Jia
Xu, Dong
Sun, Wen-Jin
Wang, Wen-Xia
Xie, Na-Na
Ruan, Qiu-Rong
Song, Jian-Xin
Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
title Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
title_full Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
title_fullStr Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
title_full_unstemmed Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
title_short Differential diagnosis of lymphoma with (18)F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy
title_sort differential diagnosis of lymphoma with (18)f-fdg pet/ct in patients with fever of unknown origin accompanied by lymphadenopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374793/
https://www.ncbi.nlm.nih.gov/pubmed/36884116
http://dx.doi.org/10.1007/s00432-023-04665-7
work_keys_str_mv AT chenjia differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy
AT xudong differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy
AT sunwenjin differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy
AT wangwenxia differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy
AT xienana differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy
AT ruanqiurong differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy
AT songjianxin differentialdiagnosisoflymphomawith18ffdgpetctinpatientswithfeverofunknownoriginaccompaniedbylymphadenopathy